Infusion Services: Care Setting Shift Drives Growth

The over $100 billion infusion therapy market is projected to continue growing at 8.6% CAGR through 2025 due to an ongoing shift in care from hospitals to outpatient and in-home settings.¹ 

Other key factors propelling this expansion of the infusion market include an aging U.S. population, increase in chronic disease, and emergence of novel treatments. As the sector keeps evolving, several factors will shape its future, such as policy changes, rising competition, and new drug development. Investor interest will continue to strengthen, driven by the significant value infusion therapy providers bring to the healthcare ecosystem. 

In our latest report covering the infusion services sector, our Healthcare & Life Sciences Group shares: 

• Deep dives into the market’s growth drivers
• Trends driving investor interest in infusion therapy
• Traits and strengths of leading infusion platforms
• Recent infusion platform M&A activity
• A market map of notable infusion companies 

To learn more about opportunities within the infusion services space, please contact our senior professionals.

1. CVS Health: Coram Study, Option Care Health Investor Presentation, July 2020; Coherent Market Insights Report, Deloitte Analysis